ACE INHIBITORS for HYPERTENSION

ACE Inhibitors for Hypertension: Benefits, Mechanism, Uses, and Side Effects

Meta Title: ACE Inhibitors for Hypertension: Mechanism, Benefits, Side Effects & Clinical Uses

Meta Description: Learn how ACE inhibitors treat hypertension, their mechanism of action, indications, contraindications, side effects, and why they are first-line therapy in many patients.

ACE Inhibitors: A Cornerstone in the Management of Hypertension

Hypertension affects more than 1.3 billion people worldwide and remains one of the leading risk factors for heart attack, stroke, chronic kidney disease, and heart failure.

Among the most widely prescribed antihypertensive medications are Angiotensin-Converting Enzyme (ACE) inhibitors. These drugs not only lower blood pressure but also protect the heart and kidneys, making them a preferred first-line treatment in many patients.

What are ACE Inhibitors?

ACE inhibitors are medications that block the Angiotensin-Converting Enzyme (ACE), preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.

Common ACE inhibitors include:

• Enalapril
• Ramipril
• Lisinopril
• Perindopril
• Captopril
• Fosinopril
• Benazepril
• Quinapril
• Trandolapril

Mechanism of Action

The Renin-Angiotensin-Aldosterone System (RAAS) plays a central role in blood pressure regulation.

ACE inhibitors work by:

• Decreasing formation of angiotensin II
• Reducing vasoconstriction
• Decreasing aldosterone secretion
• Promoting sodium and water excretion
• Increasing bradykinin levels, leading to vasodilation

The overall effect is:

• Reduced systemic vascular resistance
• Lower blood pressure
• Reduced cardiac workload
• Protection against cardiovascular and renal damage

Benefits of ACE Inhibitors

1. Effective Blood Pressure Reduction

ACE inhibitors lower both systolic and diastolic blood pressure and are recommended as first-line therapy in many adults with hypertension.

2. Kidney Protection

ACE inhibitors are especially beneficial in patients with:

• Diabetes mellitus
• Chronic kidney disease
• Albuminuria (protein in the urine)

They reduce intraglomerular pressure and slow the progression of kidney disease.

3. Heart Failure Management

ACE inhibitors:

• Reduce symptoms of heart failure
• Improve exercise tolerance
• Decrease hospitalization
• Improve survival in patients with heart failure with reduced ejection fraction (HFrEF)

4. After Myocardial Infarction

Following a heart attack, ACE inhibitors help:

• Prevent adverse cardiac remodeling
• Reduce recurrent cardiovascular events
• Improve long-term survival

5. Cardiovascular Risk Reduction

Long-term treatment lowers the risk of:

• Stroke
• Myocardial infarction
• Cardiovascular death in high-risk patients

Who Should Receive ACE Inhibitors?

ACE inhibitors are recommended for patients with hypertension, particularly those with:

• Diabetes mellitus
• Chronic kidney disease with albuminuria
• Heart failure with reduced ejection fraction
• Previous myocardial infarction
• Left ventricular systolic dysfunction

Dosage

Dosage depends on the specific medication and patient characteristics.

Examples:

• Enalapril: 5–40 mg/day
• Ramipril: 2.5–10 mg/day
• Lisinopril: 5–40 mg/day

Treatment is usually started at a low dose and increased gradually while monitoring blood pressure, kidney function, and serum potassium.

Side Effects

Common Side Effects

• Dry persistent cough
• Dizziness
• Headache
• Fatigue

Hyperkalemia

Reduced aldosterone levels may increase serum potassium, particularly in patients with chronic kidney disease or those taking potassium-sparing diuretics.

Rise in Serum Creatinine

A mild increase in serum creatinine after starting therapy is common and often reflects the drug’s effect on kidney blood flow. Significant or progressive increases require evaluation for causes such as renal artery stenosis, dehydration, or other kidney disease.

Angioedema

Although rare, angioedema is a potentially life-threatening adverse effect.

Symptoms include:

• Swelling of the lips
• Tongue swelling
• Facial swelling
• Difficulty breathing

ACE inhibitors should be discontinued immediately if angioedema occurs.

Contraindications

ACE inhibitors should not be used in:

• Pregnancy (risk of fetal injury)
• History of ACE inhibitor–induced angioedema
• Bilateral renal artery stenosis (or stenosis in a solitary functioning kidney)
• Significant hyperkalemia

Monitoring

Patients taking ACE inhibitors should have periodic assessment of:

• Blood pressure
• Serum creatinine
• Estimated GFR (eGFR)
• Serum potassium

Monitoring is especially important 1–2 weeks after starting treatment or increasing the dose.

Patients who develop a troublesome cough with an ACE inhibitor are often switched to an Angiotensin Receptor Blocker (ARB).

Practical Clinical Pearls

• Check kidney function and potassium before starting therapy.
• Reassess laboratory values within 1–2 weeks after initiation or dose adjustment.
• A persistent dry cough is a well-known class effect and may require switching to an ARB.
• Avoid potassium supplements or salt substitutes containing potassium unless advised by a healthcare professional.
• ACE inhibitors are particularly valuable in patients with hypertension plus diabetes, chronic kidney disease, or heart failure.

Frequently Asked Questions (FAQ)

Are ACE inhibitors first-line drugs for hypertension?

Yes. They are recommended as first-line therapy for many patients, especially those with diabetes, chronic kidney disease with albuminuria, or heart failure.

Why do ACE inhibitors cause a dry cough?

ACE inhibition increases bradykinin levels, which can irritate the airways and trigger a persistent, nonproductive cough.

Can ACE inhibitors damage the kidneys?

No. In most patients, they protect kidney function over the long term. A small initial rise in serum creatinine is expected in some individuals, but substantial or progressive increases should be investigated.

Can ACE inhibitors be used during pregnancy?

No. They are contraindicated during pregnancy because they can cause serious fetal harm.

Conclusion

ACE inhibitors remain one of the most important medication classes for treating hypertension. Beyond lowering blood pressure, they provide substantial protection against heart failure, chronic kidney disease progression, and cardiovascular events. Their benefits are particularly evident in patients with diabetes, albuminuric kidney disease, and reduced left ventricular function.

When prescribed appropriately and monitored with periodic assessment of kidney function and potassium levels, ACE inhibitors continue to be a cornerstone of evidence-based cardiovascular care.